tooluniverse-gpcr-structural-pharmacology

Research GPCR receptors, antibody structures, and protein interface analysis using GPCRdb, SAbDab, and PDBePISA. Retrieves receptor families, known ligands (agonists/antagonists/biased), mutations, crystal/cryo-EM structures, antibody CDR annotations, and protein-protein interface geometry. Use when asked about GPCR drug targets, receptor-ligand interactions, antibody structural data, or protein assembly interfaces.

1,202 stars

Best use case

tooluniverse-gpcr-structural-pharmacology is best used when you need a repeatable AI agent workflow instead of a one-off prompt.

Research GPCR receptors, antibody structures, and protein interface analysis using GPCRdb, SAbDab, and PDBePISA. Retrieves receptor families, known ligands (agonists/antagonists/biased), mutations, crystal/cryo-EM structures, antibody CDR annotations, and protein-protein interface geometry. Use when asked about GPCR drug targets, receptor-ligand interactions, antibody structural data, or protein assembly interfaces.

Teams using tooluniverse-gpcr-structural-pharmacology should expect a more consistent output, faster repeated execution, less prompt rewriting.

When to use this skill

  • You want a reusable workflow that can be run more than once with consistent structure.

When not to use this skill

  • You only need a quick one-off answer and do not need a reusable workflow.
  • You cannot install or maintain the underlying files, dependencies, or repository context.

Installation

Claude Code / Cursor / Codex

$curl -o ~/.claude/skills/tooluniverse-gpcr-structural-pharmacology/SKILL.md --create-dirs "https://raw.githubusercontent.com/mims-harvard/ToolUniverse/main/skills/tooluniverse-gpcr-structural-pharmacology/SKILL.md"

Manual Installation

  1. Download SKILL.md from GitHub
  2. Place it in .claude/skills/tooluniverse-gpcr-structural-pharmacology/SKILL.md inside your project
  3. Restart your AI agent — it will auto-discover the skill

How tooluniverse-gpcr-structural-pharmacology Compares

Feature / Agenttooluniverse-gpcr-structural-pharmacologyStandard Approach
Platform SupportNot specifiedLimited / Varies
Context Awareness High Baseline
Installation ComplexityUnknownN/A

Frequently Asked Questions

What does this skill do?

Research GPCR receptors, antibody structures, and protein interface analysis using GPCRdb, SAbDab, and PDBePISA. Retrieves receptor families, known ligands (agonists/antagonists/biased), mutations, crystal/cryo-EM structures, antibody CDR annotations, and protein-protein interface geometry. Use when asked about GPCR drug targets, receptor-ligand interactions, antibody structural data, or protein assembly interfaces.

Where can I find the source code?

You can find the source code on GitHub using the link provided at the top of the page.

Related Guides

SKILL.md Source

# GPCR and Structural Pharmacology Research

**GPCR pharmacology**: agonist vs antagonist vs inverse agonist vs biased agonist — each has different clinical implications. Biased agonism (preferential G-protein vs β-arrestin signaling) can separate efficacy from side effects; for example, G-protein-biased opioid agonists aim to retain analgesia while reducing β-arrestin-mediated respiratory depression. Always classify retrieved ligands by their pharmacological type, not just their chemical structure. Receptor state (active vs inactive crystal structure) determines which ligands and mutations are interpretable — an inactive-state structure is appropriate for antagonist binding analysis, active-state for agonist-bound complexes. Generic GPCR numbering (Ballesteros-Weinstein) enables cross-receptor mutation comparison; always report positions in this system alongside sequence positions.

**LOOK UP DON'T GUESS**: never assume GPCRdb entry names (e.g., `adrb2_human`) or PDB IDs — always use `GPCRdb_list_proteins` to find the correct entry name and `GPCRdb_get_structures` to confirm available structures.

Research skill integrating GPCRdb (GPCR receptor biology), SAbDab (antibody structures), and PDBePISA (protein interface analysis) to support structural pharmacology, antibody engineering, and GPCR-targeted drug discovery.

**KEY PRINCIPLES**:
1. **Receptor-first** — Identify GPCR entry name before any GPCRdb queries
2. **Ligand classification** — Distinguish agonists, antagonists, partial agonists, biased agonists
3. **Structure-guided** — Pair GPCRdb mutation data with PDB structures via PDBePISA
4. **Antibody context** — Use SAbDab for therapeutic antibody structure retrieval and CDR analysis
5. **English-first queries** — Use standard receptor names (e.g., "beta-2 adrenergic receptor") in searches; convert to GPCRdb entry names for API calls

---

## When to Use

Apply when user asks:
- "What ligands are known for [GPCR receptor]?"
- "What crystal structures exist for [receptor]?"
- "Find antibody structures targeting [antigen]"
- "Analyze the protein-protein interface in PDB [ID]"
- "What mutations affect [GPCR] function or pharmacology?"
- "Which GPCRs are in the [family] family?"
- "What are the CDR loops in antibody PDB [ID]?"
- "What is the biological assembly for [PDB ID]?"

---

## Tool Parameter Reference (CRITICAL)

| Tool | Key Parameters | Notes |
|------|---------------|-------|
| `GPCRdb_get_protein` | `protein` | GPCRdb entry name (e.g., `adrb2_human`), NOT gene symbol or UniProt accession |
| `GPCRdb_list_proteins` | `family` (optional), `protein_class` (optional) | Lists all GPCRs; filter by family slug (e.g., `"adrenoceptors"`) OR by human-readable class name via `protein_class` (e.g., `"chemokine receptors"`, `"opioid receptors"`) |
| `GPCRdb_get_structures` | `protein` (optional), `state` (optional) | `state`: `"active"`, `"inactive"`, `"intermediate"` |
| `GPCRdb_get_ligands` | `protein` | Returns agonists, antagonists, biased ligands with affinities |
| `GPCRdb_get_mutations` | `protein` | Returns mutation effects on receptor function and ligand binding |
| `SAbDab_search_structures` | `query` | Antigen name, species, or keywords; returns browse URL + metadata |
| `SAbDab_get_structure` | `pdb_id` | 4-character PDB code (e.g., `"6W41"`); returns CDR annotations |
| `SAbDab_get_summary` | (no required params) | Database statistics and summary |
| `PDBePISA_get_interfaces` | `pdb_id` | 4-character PDB code; returns all interface pairs with buried area |
| `PDBePISA_get_assemblies` | `pdb_id` | Predicted biological assemblies from crystal packing |
| `PDBePISA_get_monomer_analysis` | `pdb_id` | Per-chain solvent-accessible surface area (SASA) breakdown |

### GPCRdb Entry Name Format

GPCRdb uses its own entry name format: `{receptor_slug}_{species}`. Common examples:
- Beta-2 adrenergic receptor: `adrb2_human`
- Beta-1 adrenergic receptor: `adrb1_human`
- Mu-opioid receptor: `oprm1_human`
- Dopamine D2 receptor: `drd2_human`
- Glucagon-like peptide-1 receptor: `glp1r_human`
- CXCR4 chemokine receptor: `cxcr4_human`

If entry name is unknown, use `GPCRdb_list_proteins()` to browse and find the correct slug. You can also filter by receptor class using the `protein_class` parameter with a human-readable name — e.g., `GPCRdb_list_proteins(protein_class="chemokine receptors")` — instead of the numeric family slug. Both `family` and `protein_class` are accepted and serve overlapping purposes; prefer `protein_class` when the user provides a receptor class name.

---

## Workflow Overview

```
Phase 1: Receptor Identification (for GPCR queries)
  -> GPCRdb_list_proteins: find receptor family and entry name
  -> GPCRdb_get_protein: receptor details, family, species

Phase 2: Ligand Landscape
  -> GPCRdb_get_ligands: all known ligands by pharmacology class
  -> Cross-reference with ChEMBL/PubChem for chemical properties

Phase 3: Structural Data
  -> GPCRdb_get_structures: available PDB/EMDB structures with resolution
  -> PDBePISA_get_interfaces: interface analysis on best structure
  -> PDBePISA_get_assemblies: biological assembly determination

Phase 4: Mutation & Pharmacology Data
  -> GPCRdb_get_mutations: pharmacological mutation map
  -> Compare to ligand binding sites from structure

Phase 5: Antibody Structures (for antibody queries)
  -> SAbDab_search_structures: find structures by antigen
  -> SAbDab_get_structure: CDR annotations, chain details
  -> PDBePISA_get_interfaces: antibody-antigen interface analysis
```

---

## Phase 1: GPCR Receptor Identification

```python
# List all GPCRs in a family to find entry name (by slug)
family_list = GPCRdb_list_proteins(family="adrenoceptors")

# Filter by human-readable class name (new -- preferred when user says e.g. "chemokine receptors")
chemokine_list = GPCRdb_list_proteins(protein_class="chemokine receptors")

# Browse all GPCRs (no family filter)
all_gpcrs = GPCRdb_list_proteins()

# Get detailed protein info once you have the entry name
receptor = GPCRdb_get_protein(protein="adrb2_human")
# Returns: family classification, endogenous ligands, tissue expression,
#          GPCRdb-specific annotations, sequence features
```

## Phase 2: Ligand Landscape

```python
# Get all known ligands for a GPCR
ligands = GPCRdb_get_ligands(protein="adrb2_human")
# Returns: ligand names, types (agonist/antagonist/partial/biased/allosteric),
#          binding affinities (Ki, IC50, EC50), references

# Ligand type classification:
# - Agonist: activates receptor
# - Antagonist/Inverse agonist: blocks or suppresses receptor
# - Partial agonist: submaximal activation
# - Biased agonist: selective signaling (Gs vs. beta-arrestin bias)
# - Positive/Negative allosteric modulator (PAM/NAM)
```

After retrieving ligands from GPCRdb, optionally cross-reference with:
- `PubChem_get_CID_by_compound_name(compound_name=ligand_name)` — get CID, SMILES
- `ChEMBL_search_molecules(query=ligand_name)` — get ChEMBL ID, bioactivity data

## Phase 3: Structural Data

```python
# Get available crystal/cryo-EM structures
structures = GPCRdb_get_structures(protein="adrb2_human", state="inactive")
# state options: "active", "inactive", "intermediate" (omit for all)
# Returns: PDB IDs, resolution, ligand in structure, publication info

# Analyze a specific structure's interfaces
interfaces = PDBePISA_get_interfaces(pdb_id="2rh1")  # adrb2 inactive structure
# Returns: interface pairs, buried solvent-accessible area (BSA),
#          interface residues, hydrogen bonds, salt bridges

# Determine biological assembly
assemblies = PDBePISA_get_assemblies(pdb_id="2rh1")
# Returns: predicted oligomeric state, assembly stability score,
#          subunit composition

# Per-chain SASA breakdown
monomers = PDBePISA_get_monomer_analysis(pdb_id="2rh1")
# Returns: accessible/buried surface area per chain
```

**Interface Analysis Interpretation**:
- BSA > 1500 Ų: Strong interface (likely biologically relevant)
- BSA 800-1500 Ų: Moderate interface
- BSA < 800 Ų: Weak or crystal contact

## Phase 4: Mutation Data

```python
# Get all mutations characterized for a GPCR
mutations = GPCRdb_get_mutations(protein="adrb2_human")
# Returns: mutation positions (generic GPCR numbering), effects on:
#   - Expression/folding
#   - Ligand binding (affinity changes)
#   - G-protein coupling
#   - Receptor activation

# Generic GPCR numbering (Ballesteros-Weinstein):
# e.g., 3.32 = position 32 in TM helix 3 — conserved across GPCR classes
```

## Phase 5: Antibody Structure Retrieval

```python
# Search SAbDab for antibody structures by antigen
results = SAbDab_search_structures(query="EGFR", limit=20)
# Returns: browse URL + metadata table of matching structures

# Get detailed annotations for a specific antibody structure
structure = SAbDab_get_structure(pdb_id="1IQD")
# Returns: VH/VL chain IDs, CDR1-3 (Kabat/IMGT), antigen info,
#          heavy/light chain types, resolution

# Get database overview
summary = SAbDab_get_summary()
# Returns: total structures, species breakdown, antigen coverage stats
```

**CDR Analysis**:
- CDR-H3 is most variable and typically dominates antigen contact
- CDR length distribution: SAbDab provides Kabat, Chothia, and IMGT numbering
- After retrieving SAbDab structure, use `PDBePISA_get_interfaces(pdb_id=...)` to compute antibody-antigen buried surface area

---

## Common Research Patterns

### Pattern 1: GPCR Drug Target Profiling
```
Input: GPCR name (e.g., "GLP-1 receptor")
Flow: GPCRdb_list_proteins -> find "glp1r_human" ->
      GPCRdb_get_protein (receptor details) ->
      GPCRdb_get_ligands (approved + investigational drugs) ->
      GPCRdb_get_structures (available PDB structures) ->
      PDBePISA_get_interfaces on best structure ->
      GPCRdb_get_mutations (pharmacological mutants)
Output: Complete GPCR pharmacology profile with structural context
```

### Pattern 2: Antibody-Antigen Interface Analysis
```
Input: Target antigen (e.g., "PD-L1") or specific PDB code
Flow: SAbDab_search_structures(query="PD-L1") ->
      SAbDab_get_structure(pdb_id="best hit") (CDR annotations) ->
      PDBePISA_get_interfaces(pdb_id=...) (buried area, key contacts) ->
      PDBePISA_get_assemblies (assembly context)
Output: CDR sequences, epitope contact residues, interface energetics
```

### Pattern 3: GPCR Family Survey
```
Input: Drug class question (e.g., "beta-adrenergic receptors")
Flow: GPCRdb_list_proteins(family="adrenoceptors") ->
      GPCRdb_get_protein per receptor (adrb1/2/3) ->
      GPCRdb_get_ligands per receptor (selectivity landscape) ->
      GPCRdb_get_structures per receptor (structural coverage)
Output: Family-wide selectivity map, structural availability, ligand classes
```

### Pattern 4: Structure Interface Characterization
```
Input: PDB code
Flow: PDBePISA_get_assemblies (oligomeric state) ->
      PDBePISA_get_interfaces (all interface pairs ranked by BSA) ->
      PDBePISA_get_monomer_analysis (per-chain surface burial)
Output: Biologically relevant assembly, key interface residues, buried areas
```

---

## Tool Combinations with Other Skills

This skill complements other ToolUniverse skills:

| Goal | This skill provides | Complement with |
|------|--------------------|--------------------|
| GPCR drug discovery | Receptor/ligand/structure data | `tooluniverse-binder-discovery` for virtual screening |
| Antibody engineering | SAbDab structure + CDR data | `tooluniverse-antibody-engineering` for optimization |
| Variant impact on GPCR | GPCRdb mutation effects | `tooluniverse-variant-functional-annotation` for ACMG |
| Target validation | GPCR expression, ligand data | `tooluniverse-drug-target-validation` |
| PDB structure analysis | PDBePISA interfaces | `tooluniverse-protein-structure-retrieval` for RCSB/PDBe |

---

## Fallback Chains

| Primary Tool | Fallback | Use When |
|-------------|----------|----------|
| `GPCRdb_get_protein` | UniProt search + PubMed | Entry name unknown or non-GPCR target |
| `GPCRdb_get_ligands` | ChEMBL bioactivity search | Receptor not in GPCRdb |
| `GPCRdb_get_structures` | RCSB PDB text search | Structures not yet in GPCRdb |
| `SAbDab_search_structures` | RCSB PDB antibody search | Antigen not indexed in SAbDab |
| `PDBePISA_get_interfaces` | PDBe graph API | PDBePISA returns no interfaces |

---

## Completeness Checklist

For GPCR profiling:
- [ ] Entry name resolved via `GPCRdb_list_proteins` or `GPCRdb_get_protein`
- [ ] Receptor family and class documented
- [ ] Ligand landscape retrieved with pharmacology types
- [ ] Available structures listed with resolution and state
- [ ] Best structure analyzed with PDBePISA (interfaces + assembly)
- [ ] Mutation data retrieved for pharmacological context

For antibody structure:
- [ ] SAbDab search run with antigen name
- [ ] Best structure retrieved with `SAbDab_get_structure`
- [ ] CDR1-3 sequences extracted for VH and VL chains
- [ ] Antibody-antigen interface analyzed with PDBePISA
- [ ] Buried surface area and key contact residues documented

---

## Key References

- GPCRdb: https://gpcrdb.org — standardized GPCR data with generic numbering
- SAbDab: https://opig.stats.ox.ac.uk/webapps/newsabdab/sabdab — structural antibody database
- PDBePISA: https://www.ebi.ac.uk/pdbe/pisa — protein interface analysis

Related Skills

tooluniverse

1202
from mims-harvard/ToolUniverse

Router skill for ToolUniverse tasks. First checks if specialized tooluniverse skills (105+ skills covering disease/drug/target research, gene-disease associations, clinical decision support, genomics, epigenomics, proteomics, comparative genomics, chemical safety, toxicology, systems biology, and more) can solve the problem, then falls back to general strategies for using 2300+ scientific tools. Covers tool discovery, multi-hop queries, comprehensive research workflows, disambiguation, evidence grading, and report generation. Use when users need to research any scientific topic, find biological data, or explore drug/target/disease relationships. ALSO USE for any biology, medicine, chemistry, pharmacology, or life science question — even simple factoid questions like "how many X in protein Y", "what drug interacts with Z", "what gene causes disease W", or "translate this sequence". These questions benefit from database lookups (UniProt, PubMed, ChEMBL, ClinVar, GWAS Catalog, etc.) rather than answering from memory alone. When in doubt about a scientific fact, USE THIS SKILL to verify against real databases.

tooluniverse-variant-to-mechanism

1202
from mims-harvard/ToolUniverse

End-to-end variant-to-mechanism analysis: given a genetic variant (rsID or coordinates), trace its functional impact from regulatory context (GWAS, eQTL, RegulomeDB, ENCODE) through target gene identification (GTEx, OpenTargets L2G) to downstream pathway and disease biology (STRING, Reactome, GO enrichment, disease associations). Produces an evidence-graded mechanistic narrative linking genotype to phenotype. Use when asked "how does this variant cause disease?", "what is the mechanism of rs7903146?", "trace variant to pathway", or "connect this GWAS hit to biology".

tooluniverse-variant-interpretation

1202
from mims-harvard/ToolUniverse

Systematic clinical variant interpretation from raw variant calls to ACMG-classified recommendations with structural impact analysis. Aggregates evidence from ClinVar, gnomAD, CIViC, UniProt, and PDB across ACMG criteria. Produces pathogenicity scores (0-100), clinical recommendations, and treatment implications. Use when interpreting genetic variants, classifying variants of uncertain significance (VUS), performing ACMG variant classification, or translating variant calls to clinical actionability.

tooluniverse-variant-functional-annotation

1202
from mims-harvard/ToolUniverse

Comprehensive functional annotation of protein variants — pathogenicity, population frequency, structural context, and clinical significance. Integrates ProtVar (map_variant, get_function, get_population) for protein-level mapping and structural context, ClinVar for clinical classifications, gnomAD for population frequency with ancestry data, CADD for deleteriousness scores, and ClinGen for gene-disease validity. Produces a structured variant annotation report with evidence grading. Use when asked about protein variant impact, missense variant pathogenicity, ProtVar annotation, variant functional context, or combining population and structural evidence for a variant.

tooluniverse-variant-analysis

1202
from mims-harvard/ToolUniverse

Production-ready VCF processing, variant annotation, mutation analysis, and structural variant (SV/CNV) interpretation for bioinformatics questions. Parses VCF files (streaming, large files), classifies mutation types (missense, nonsense, synonymous, frameshift, splice, intronic, intergenic) and structural variants (deletions, duplications, inversions, translocations), applies VAF/depth/quality/consequence filters, annotates with ClinVar/dbSNP/gnomAD/CADD via ToolUniverse, interprets SV/CNV clinical significance using ClinGen dosage sensitivity scores, computes variant statistics, and generates reports. Solves questions like "What fraction of variants with VAF < 0.3 are missense?", "How many non-reference variants remain after filtering intronic/intergenic?", "What is the pathogenicity of this deletion affecting BRCA1?", or "Which dosage-sensitive genes overlap this CNV?". Use when processing VCF files, annotating variants, filtering by VAF/depth/consequence, classifying mutations, interpreting structural variants, assessing CNV pathogenicity, comparing cohorts, or answering variant analysis questions.

tooluniverse-vaccine-design

1202
from mims-harvard/ToolUniverse

Design and evaluate vaccine candidates using computational immunology tools. Covers epitope prediction (MHC-I/II binding via IEDB), population coverage analysis, antigen selection, adjuvant matching, and immunogenicity assessment. Integrates IEDB for epitope prediction, UniProt for antigen sequences, PDB/AlphaFold for structural epitopes, BVBRC for pathogen proteomes, and literature for clinical precedent. Use when asked about vaccine design, epitope prediction, immunogenicity, MHC binding, T-cell epitopes, B-cell epitopes, or population coverage for vaccine candidates.

tooluniverse-toxicology

1202
from mims-harvard/ToolUniverse

Assess chemical and drug toxicity via adverse outcome pathways, real-world adverse event signals, and toxicogenomic evidence. Integrates AOPWiki (AOPWiki_list_aops, AOPWiki_get_aop) for mechanism- level pathway tracing, FAERS for post-market adverse event quantification, OpenFDA for label mining, and CTD for chemical-gene-disease evidence. Produces structured toxicity reports with evidence grading (T1-T4). Use when asked about toxicity mechanisms, adverse outcome pathways, AOP mapping, FAERS signal detection, or chemical-disease relationships for drugs or environmental chemicals.

tooluniverse-target-research

1202
from mims-harvard/ToolUniverse

Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.

tooluniverse-systems-biology

1202
from mims-harvard/ToolUniverse

Comprehensive systems biology and pathway analysis using multiple pathway databases (Reactome, KEGG, WikiPathways, Pathway Commons, BioModels). Performs pathway enrichment, protein-pathway mapping, keyword searches, and systems-level analysis. Use when analyzing gene sets, exploring biological pathways, or investigating systems-level biology.

tooluniverse-structural-variant-analysis

1202
from mims-harvard/ToolUniverse

Comprehensive structural variant (SV) analysis skill for clinical genomics. Classifies SVs (deletions, duplications, inversions, translocations), assesses pathogenicity using ACMG-adapted criteria, evaluates gene disruption and dosage sensitivity, and provides clinical interpretation with evidence grading. Use when analyzing CNVs, large deletions/duplications, chromosomal rearrangements, or any structural variants requiring clinical interpretation.

tooluniverse-structural-proteomics

1202
from mims-harvard/ToolUniverse

Integrate structural biology data with proteomics for drug target validation. Retrieves protein structures from PDB (RCSB, PDBe), AlphaFold predictions, antibody structures (SAbDab), GPCR data (GPCRdb), binding pocket analysis (ProteinsPlus), and ligand interactions (BindingDB). Use when asked to find structures for a drug target, identify binding site ligands, cross-validate drug binding with structural data, assess structural druggability, or compare experimental vs predicted structures.

tooluniverse-stem-cell-organoid

1202
from mims-harvard/ToolUniverse

Research stem cells, iPSCs, organoids, and cell differentiation using ToolUniverse tools. Covers pluripotency marker identification, differentiation pathway analysis, organoid model characterization, cell type annotation, and disease modeling. Integrates CellxGene/HCA for single-cell atlas data, CellMarker for cell type markers, GEO for stem cell datasets, and pathway tools for differentiation signaling. Use when asked about stem cells, iPSCs, organoids, cell reprogramming, pluripotency, differentiation protocols, or 3D culture models.